Abstract
Routine use of mupirocin to prevent staphylococcal infections is controversial. We assessed attitudes and practices of healthcare professionals attending the Fourth Decennial International Conference on Nosocomial and Healthcare-Associated Infections regarding mupirocin prophylaxis. Eighty percent of participants did not use mupirocin routinely. At the end of the session, 58% indicated they would consider increased use of mupirocin.
| Original language | English |
|---|---|
| Article number | 04423 |
| Pages (from-to) | 745-749 |
| Number of pages | 5 |
| Journal | Infection Control and Hospital Epidemiology |
| Volume | 21 |
| Issue number | 11 |
| DOIs | |
| Publication status | Published - 1 Jan 2000 |
| Externally published | Yes |
Fingerprint
Cite this
Roth, V. R., Murphy, C., Perl, T. M., DeMaria, A., Sohn, A. H., Sinkowitz-Cochran, R. L., & Jarvis, W. R. (2000). Should we routinely use mupirocin to prevent staphylococcal infections? Infection Control and Hospital Epidemiology, 21(11), 745-749. [04423]. https://doi.org/10.1086/501720